Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal

With the search for a COVID-19 vaccine in hyperdrive, drugmakers have signed a wave of massive manufacturing tie-ups to help secure capacity for a possible winner. Now, Moderna has tapped CDMO Catalent to help out on the finishing stages of its shot with the goal of churning out millions of doses within months.